Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy.

Background: Rebound hypoxemia may occur after cessation of corticosteroid therapy for COVID-19 pneumonitis. We aimed to determine the incidence of this phenomenon in mechanically ventilated patients with COVID-19 completing corticosteroid therapy. Methods: We conducted a retrospective observational...

Descripción completa

Detalles Bibliográficos
Publicado en:Respiratory Care Vol. 70; no. 8; pp. 987 - 995
Autores principales: Costa-Pinto, Rahul, Rotherham, Hannah, O'Brien, Zachary, Perera, Padeepa, Chen, Vicky, Massarany, Christopher, Xu, Brett, Bellomo, Rinaldo
Formato: research tables/charts Journal Article
Publicado: Mary Ann Liebert, Inc. Aug2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=187150237&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 187150237
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00201324
        4GG
      jtl: Respiratory Care
      issn: 00201324
      maglogo: N
    pubinfo:
      dt: Aug2025
      vid: 70
      iid: 8
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        187150237
        187150237
        187150237
        10.1089/respcare.12494
        187150237
      ppf: 987
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy.
      aug:
        au:
          Costa-Pinto, Rahul
          Rotherham, Hannah
          O'Brien, Zachary
          Perera, Padeepa
          Chen, Vicky
          Massarany, Christopher
          Xu, Brett
          Bellomo, Rinaldo
        affil: Drs. Costa-Pinto, Massarany, Xu and Prof. Bellomo are affiliated with Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia.
      sug:
        subj:
          Anoxemia Epidemiology
          COVID-19 Complications
          COVID-19
          Respiration, Artificial
          Glucocorticoids Therapeutic Use
          Dexamethasone Therapeutic Use
          Dexamethasone Administration and Dosage
          Treatment Duration
          Treatment Outcomes Evaluation
          Human
          Male
          Female
          Retrospective Design
          Record Review
          Nonexperimental Studies
          Tertiary Health Care
          Australia
          Descriptive Statistics
          Data Analysis Software
          Wilcoxon Rank Sum Test
          Pearson's Correlation Coefficient
          Chi Square Test
          Fisher's Exact Test
          Organizing Pneumonia
          C-Reactive Protein
          Treatment Withdrawal
          Oxygen Saturation
          Intensive Care Units
          Male
          Female
      ab: Background: Rebound hypoxemia may occur after cessation of corticosteroid therapy for COVID-19 pneumonitis. We aimed to determine the incidence of this phenomenon in mechanically ventilated patients with COVID-19 completing corticosteroid therapy. Methods: We conducted a retrospective observational cohort study across 2 tertiary ICUs from September to December 2021. We included all adult patients receiving invasive mechanical ventilation on completion of a 10-day course of dexamethasone for COVID pneumonitis. Our primary outcome was change in PaO2/FIO2 ratio in the 7 days following cessation of dexamethasone. Secondary outcomes included duration of ventilation, frequency of corticosteroid recommencement, and mortality. Results: We studied 88 subjects. Median age was 61 years (interquartile range [IQR] 51–67), and median duration of mechanical ventilation was 14 days (IQR 11–26). On completion of dexamethasone, 62 subjects (70%) remained off corticosteroid therapy for the subsequent 7 days. Of these, 63% (n = 20) had a stable PaO2/FIO2 ratio on day 7 (mean change 197 ± 42 mm Hg to 258 ± 83 mm Hg). Subjects who had a reduction in PaO2/FIO2 ratio >20 mm Hg by day 7 (mean change 214 ± 68 mm Hg to 152 ± 78 mm Hg) were more likely to die in hospital (P <.001). These subjects had a higher C-reactive protein level at time of steroid cessation (204 ± 87 mg/L, P =.17), which remained persistently elevated (206 ± 89 mg/L, P =.01) on day 7. The 30% of subjects who recommenced steroids required a longer duration of ventilation (13.5 vs 24.5 d, P =.002) but showed no differences in ICU mortality (19% vs 27%, P =.43). Conclusions: Rebound hypoxemia and steroid recommencement were common occurrences in mechanically ventilated subjects with COVID-19. Rebound hypoxemia was associated with higher mortality. Steroid recommencement was associated with longer duration of mechanical ventilation but no significant difference in mortality.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N